These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11377711)

  • 1. Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype.
    Chayama K; Suzuki F; Tsubota A; Akuta N; Someya T; Kobayashi M; Arase Y; Saitoh S; Suzuki Y; Ikeda K; Kumada H
    J Virol Methods; 2001 Jun; 95(1-2):33-45. PubMed ID: 11377711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon alpha.
    Kobayashi M; Chayama K; Arase Y; Tsubota A; Saitoh S; Suzuki Y; Kobayashi M; Kobayashi M; Ikeda K; Matsuda M; Koike H; Hashimoto M; Kumada H
    J Gastroenterol; 1999 Feb; 34(1):94-9. PubMed ID: 10204617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test.
    Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
    J Clin Microbiol; 2000 Aug; 38(8):2933-9. PubMed ID: 10921954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.
    Yu ML; Chuang WL; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
    J Clin Pathol; 1999 Nov; 52(11):807-11. PubMed ID: 10690168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay.
    Lu RH; Hwang SJ; Chan CY; Chang FY; Lee SD
    J Clin Lab Anal; 1998; 12(2):121-5. PubMed ID: 9524297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia.
    Furusyo N; Hayashi J; Kashiwagi K; Nakashima H; Nabeshima S; Sawayama Y; Kinukawa N; Kashiwagi S
    Dig Dis Sci; 2002 Mar; 47(3):535-42. PubMed ID: 11911338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of hepatitis C virus RNA predict non-response to interferon therapy: comparison of two commercial assays.
    Soffredini R; Rumi MG; Del Ninno E; Parravicini ML; Russo A; Colombo M
    J Viral Hepat; 1999 Jan; 6(1):65-71. PubMed ID: 10847132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
    Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C
    J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy.
    Takahashi M; Saito H; Higashimoto M; Atsukawa K; Ishii H
    J Clin Microbiol; 2005 Jan; 43(1):186-91. PubMed ID: 15634970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
    Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
    J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C.
    Reichard O; Norkrans G; Frydén A; Braconier JH; Sönnerborg A; Weiland O
    Scand J Infect Dis; 1998; 30(5):441-6. PubMed ID: 10066040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral kinetics can predict early response to alpha-interferon in chronic hepatitis C.
    Walsh KM; Good T; Cameron S; Thorburn D; McCruden EA; Mills PR; Morris AJ
    Liver; 1998 Jun; 18(3):191-5. PubMed ID: 9716230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
    Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T
    J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The factors associated with viral relapse after interferon treatment in chronic hepatitis C patients].
    Ma L; Zhao H; Xie Y; Li MH; Xu DZ; Lu ZM; Luo KX; Jia JD; Wang YM; Zhao GZ; Zhang SL; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):565-8. PubMed ID: 16938164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin.
    Su PY; Yen HH; Hsu YC; Wu SS; Kor CT; Su WW
    Kaohsiung J Med Sci; 2016 Jul; 32(7):381-6. PubMed ID: 27450028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of hepatitis C virus RNA counts by second generation HCV bDNA-probe in chronic hepatitis C based on the HCV genotype.
    Kobayashi M; Kumada H; Arase Y; Chayama K; Kobayashi M; Tsubota A; Koida I; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Miyano Y; Mizoshita K; Matsuda M; Koike H; Hashimoto M
    J Gastroenterol; 1998 Apr; 33(2):223-8. PubMed ID: 9605953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus genotypes and hepatic fibrosis regulate 24-h decline of serum hepatitis C virus RNA during interferon therapy in patients with chronic hepatitis C.
    Karino Y; Toyota J; Sugawara M; Miyazaki K; Kuwata Y; Yamazaki K; Sato T; Ohmura T; Matsushima T
    J Gastroenterol Hepatol; 2003 Apr; 18(4):404-10. PubMed ID: 12653888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of viral loads in patients with chronic hepatitis C with AMPLICOR HCV MONITOR version 1.0, COBAS HCV MONITOR version 2.0, and QUANTIPLEX HCV RNA version 2.0 assays.
    Martinot-Peignoux M; Le Breton V; Fritsch S; Le Guludec G; Labouret N; Keller F; Marcellin P
    J Clin Microbiol; 2000 Jul; 38(7):2722-5. PubMed ID: 10878070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of quantification of viral load in patients infected with hepatitis C virus: quantiplex HCV RNA assay and amplicor monitor assay.
    Olaso V; Córdoba J; López B; Argüello L; Molina J; Lainez B; Ortiz V; Pastor M; Prieto M; Berenguer J
    Rev Esp Enferm Dig; 1999 Aug; 91(8):569-82. PubMed ID: 10491489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.